Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24791276 | 0.91 | — | — | |
| SCHEMBL24791277 | 0.89 | POLRMT (0.32) | RIPK1 | |
| SCHEMBL24790430 | 0.86 | RIPK1 (0.32) | RIPK1 | |
| SCHEMBL24312581 | 0.83 | CA12 (0.33) | RIPK1CA12CA1CA2CA9 | |
| SCHEMBL24917062 | 0.81 | POLRMT (0.34) | RIPK1 | |
| SCHEMBL24790485 | 0.80 | PIK3CD (0.35) | RIPK1 | |
| SCHEMBL24790936 | 0.80 | LMNA (0.31) | — | |
| SCHEMBL24791782 | 0.78 | RIPK1 (0.31) | RIPK1 | |
| SCHEMBL25916692 | 0.78 | TMPRSS2 (0.33) | CA12CA1CA2CA9CA14 | |
| SCHEMBL24917064 | 0.78 | PIK3CD (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022265964-A1 | ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS | VenatoRx Pharmaceuticals, Inc. (US) | 2022-12-22 | — | — | WO | disclosed |